Mark Thursz is Professor of Hepatology at Imperial College where he is head of the Digestive Diseases Division and lead clinician for hepatology at St Mary’s Hospital, London. His clinical interests are in viral hepatitis, alcoholic and fatty liver disease.Prof. Thursz is
Prof. Thursz is chief investigator on two multi-centre trials: The warfarin anticoagulation for liver fibrosis in patients transplanted for hepatitis C (WAFT-C) trial and the steroids or pentoxifylline for alcoholic hepatitis (STOPAH) trial. He is chief investigator on the PROLIFICA programme in West Africa.